Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.94M Buy
54,996
+30,778
+127% +$2.87M 0.29% 78
2024
Q4
$2.41M Sell
24,218
-34,567
-59% -$3.56M 0.14% 93
2024
Q3
$6.68M Sell
58,785
-330,882
-85% -$39.3M 0.32% 70
2024
Q2
$42.5M Buy
389,667
+138,091
+55% +$17.8M 2.34% 11
2024
Q1
$33.2M Sell
251,576
-138,091
-35% -$17M 1.62% 22
2023
Q4
$42.5M Sell
389,667
-95,444
-20% -$9.91M 2.34% 11
2023
Q3
$49.9M Sell
485,111
-5,430
-1% -$585K 3.07% 5
2023
Q2
$55.7M Sell
490,541
-57,493
-10% -$6.53M 3.22% 3
2023
Q1
$58M Sell
548,034
-34,282
-6% -$3.7M 3.15% 4
2022
Q4
$64.5M Sell
582,316
-14,235
-2% -$1.46M 3.42% 1
2022
Q3
$51.7M Buy
596,551
+139,416
+30% +$12.4M 3% 7
2022
Q2
$41.7M Buy
457,135
+150,959
+49% +$13.4M 2.33% 12
2022
Q1
$25.1M Buy
306,176
+145,881
+91% +$11.5M 1.07% 32
2021
Q4
$12.3M Buy
160,295
+43,530
+37% +$3.47M 0.5% 52
2021
Q3
$8.77M Sell
116,765
-4,570
-4% -$348K 0.35% 54
2021
Q2
$9.37M Sell
121,335
-243,369
-67% -$18.1M 0.34% 60
2021
Q1
$26.8M Sell
364,704
-418,308
-53% -$30.9M 0.95% 37
2020
Q4
$61.1M Sell
783,012
-30,424
-4% -$2.33M 2.09% 20
2020
Q3
$64.3M Sell
813,436
-325,645
-29% -$25.5M 2.21% 19
2020
Q2
$84M Buy
1,139,081
+158,649
+16% +$11.9M 2.84% 9
2020
Q1
$72M Buy
+980,432
New +$77.1M 2.68% 10
2019
Q3
$13.7M Buy
170,395
+13,287
+8% +$1.06M 0.38% 67
2019
Q2
$12.6M Buy
157,108
+16,109
+11% +$1.23M 0.34% 74
2019
Q1
$11.2M Sell
140,999
-172,456
-55% -$12.9M 0.3% 86
2018
Q4
$22.9M Sell
313,455
-170,763
-35% -$12.1M 0.57% 61
2018
Q3
$32.8M Sell
484,218
-12,468
-3% -$794K 0.69% 52
2018
Q2
$28.8M Buy
+496,686
New +$28M 0.57% 65

Other funds holding MRK

Unigestion Holding's MRK Position: Q1 2025 in Review

Unigestion Holding increased its Merck (MRK) stake by 127% in Q1 2025, buying an estimated $2.87M and bringing the position to 54,996 shares worth $4.94M. The position accounts for 0.29% of the portfolio, ranked #78.

Unigestion Holding first reported a position in MRK in Q2 2018 and has held it in 27 quarters since. The position peaked at $84M in Q2 2020. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Unigestion Holding held 54,996 shares of Merck worth $4.94M as of Q1 2025.
  • Unigestion Holding bought 30,778 Merck shares in Q1 2025, an estimated $2.87M.
  • Merck made up 0.29% of Unigestion Holding's portfolio in Q1 2025, its #78 holding.
  • Unigestion Holding first reported a position in Merck in Q2 2018 and has held it in 27 quarters since.
  • Unigestion Holding's Merck position peaked at $84M in Q2 2020.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.